Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01406132 · ClinicalTrials.gov registry record · Phase 1
A Study to Assess the Pharmacokinetics of ASP015K in Healthy Male Subjects
A Phase 1 study, sponsored by Astellas Pharma.
- Completed
- Registry status
- Phase 1
- Development phase
- 6
- Enrollment target
NCT01406132 is a Phase 1 study that has completed, run by Astellas Pharma. The registered enrollment target is 6 participants.
The verdict
NCT01406132, a Phase 1 study, has completed, sponsored by Astellas Pharma.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 6 participants
- Enrollment target
Study Summary
The objective of this study is to evaluate pharmacokinetics, in particular the routes of excretion and extent of metabolism of ASP015K after a single oral dose of 14C-labeled ASP015K.
Interventions
- DRUG ASP015K
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2009-12 |
| Est. Completion | 2010-01 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01406132
The ClinicalTrials.gov registry entry for NCT01406132 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Astellas Pharma, which has 165 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which ASP015K is the first listed.
NCT01406132 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01406132 about?
NCT01406132 is a clinical study titled "A Study to Assess the Pharmacokinetics of ASP015K in Healthy Male Subjects". The objective of this study is to evaluate pharmacokinetics, in particular the routes of excretion and extent of metabolism of ASP015K after a single oral dose of 14C-labeled ASP015K.
What is the current status of trial NCT01406132?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 6 participants. The study started on 2009-12. Estimated completion is 2010-01.
What interventions are being tested in trial NCT01406132?
The interventions under investigation include: ASP015K (DRUG).
Who is sponsoring clinical trial NCT01406132?
This trial is sponsored by Astellas Pharma, which has 165 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.